Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies (IRO’s). It forms the second largest site network in the world with more than 100 sites across 5 countries on 2 continents. Its unique ownership model combines the strengths of 10 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs. Its member companies have over 100 years of combined experience and completed more than 7,000 studies helping to evaluate thousands of new drugs and treatments in more than 140,000 patients. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. hyperCORE’s partner members are: AGA Clinical Trials of Hialeah, Florida Alcanza Clinical Research of Methuen, Massachusetts Apex Trials (NutraSource) of Guelph, Ontario, Canada Benchmark Research of Austin, Texas Centricity Research of Columbus, Georgia FOMAT Medical Research of Oxnard, California LUCAS Research of Morehead City, North Carolina TrueBlue Clinical Research of Tampa, Florida Quality Clinical Research of Omaha, Nebraska
